Mauskopf, J., Klesse, M., Lee, S., & Herrera-Taracena, G. (2013).
The burden of influenza complications in different high-risk groups: a targeted literature review. Journal of medical economics, 16(2), 264-277.
Whitley, R. J., & Monto, A. S. (2006).
Prevention and treatment of influenza in high‐risk groups: Children, pregnant women, immunocompromised hosts, and nursing home residents.
Schuchat, A., Anderson, L. J., Rodewald, L. E., Cox, N. J., Hajjeh, R., Pallansch, M. A., ... & Wharton, M. (2018).
Progress in vaccine-preventable and respiratory infectious diseases—first 10 years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015. Emerging infectious diseases, 24(7), 1178.
Griffin, M. R., Monto, A. S., Belongia, E. A., Treanor, J. J., Chen, Q., Chen, J., ... & US Flu-VE Network. (2011).
Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 US communities. PloS one, 6(8), e23085.
Wolff, G. G. (2020). Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017–2018 influenza season. Vaccine, 38(2), 350-354.